TKNO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 16:00):

Stats
Today's Volume	13 275.00
Average Volume	12 338.00
Market Cap	82.06M
EPS	$0 ( 2024-03-11 )
Next earnings date	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.730
ATR14	$0.0110 (0.55%)

Insider Trading

Date	Person	Action	Amount	type
2022-08-16	Grossman Paul David	Buy	4 386	Common Stock
2022-08-15	Grossman Paul David	Buy	4 826	Common Stock
2023-08-31	Mcnamara Robert	Sell	12 292	Non-Qualified Stock Option (right to buy)
2023-06-02	Mcnamara Robert	Buy	18 815	Common Stock
2023-08-31	Mcnamara Robert	Sell	18 815	Common Stock

INSIDER POWER
97.73
Last 82 transactions
Buy: 28 174 863 \| Sell: 2 326 861

Alpha Teknova, Inc. Correlation

10 Most Positive Correlations
AGNCM	0.863
BRKH	0.861
DOOO	0.859
CMTL	0.859
BTAI	0.841
FLL	0.835
CVCY	0.834
CLGN	0.828
EUSG	0.825
EUFN	0.815

10 Most Negative Correlations
CMLF	-0.809

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Alpha Teknova, Inc. Financials

Annual	2023
Revenue:	$36.68M
Gross Profit:	$9.15M (24.94 %)
EPS:	$-1.160

Q4	2023
Revenue:	$7.87M
Gross Profit:	$1.05M (13.31 %)
EPS:	$-0.260

Q3	2023
Revenue:	$8.17M
Gross Profit:	$1.47M (18.02 %)
EPS:	$-0.340

Q2	2023
Revenue:	$11.53M
Gross Profit:	$5.07M (43.95 %)
EPS:	$-0.250

Financial Reports:

No articles found.

Alpha Teknova, Inc.

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.